Difference between revisions of "EffectEvidenceSynthesis FHIR Resource Proposal"
BrianAlper (talk | contribs) |
BrianAlper (talk | contribs) |
||
| Line 87: | Line 87: | ||
<!--Key resources are justified by CCDA, for resources not deemed "key", what interest is there by implementers in using this particular resource. Provide named implementations if possible - ideally provide multiple independent implementations. --> | <!--Key resources are justified by CCDA, for resources not deemed "key", what interest is there by implementers in using this particular resource. Provide named implementations if possible - ideally provide multiple independent implementations. --> | ||
| + | |||
| + | Many knowledge producers who express the biomedical research community knowledge will be the implementers using this resources. Examples of these knowledge producers include Agency for Healthcare Research and Quality (AHRQ), Centers for Disease Control and Prevention (CDC), Cochrane, Duodecim Medical Publications Ltd (from the Finnish Medical Society), EBSCO Health, MAGIC (stands for Making GRADE the Irresistible Choice), and numerous guideline development organizations. | ||
==Content sources== | ==Content sources== | ||
Revision as of 13:56, 9 September 2018
This page documents a Pending FHIR Resource Proposal
Contents
- 1 effectEvidenceSynthesis
- 1.1 Owning work group name
- 1.2 Committee Approval Date:
- 1.3 Contributing or Reviewing Work Groups
- 1.4 FHIR Resource Development Project Insight ID
- 1.5 Scope of coverage
- 1.6 RIM scope
- 1.7 Resource appropriateness
- 1.8 Expected implementations
- 1.9 Content sources
- 1.10 Example Scenarios
- 1.11 Resource Relationships
- 1.12 Resource Boundaries
- 1.13 Timelines
- 1.14 gForge Users
- 1.15 When Resource Proposal Is Complete
- 1.16 FMG Notes
effectEvidenceSynthesis
Owning work group name
Committee Approval Date:
June 22, 2018
Contributing or Reviewing Work Groups
- Clinical Decision Support
- Clinical Quality Information
- Biomedical Research and Regulation
FHIR Resource Development Project Insight ID
1422
Scope of coverage
The scope of the effectEvidenceSynthesis resource is to describe the estimates of an effect of an exposure on an outcome where the effect estimates are derived from the combination of research studies. Effect estimates are a measure of difference between the exposure state and an alternative exposure state (often called the control or comparator state)
Expressing effect estimates is done throughout reporting of biomedical research, systematic reviews, and clinical reference across all disciplines.
RIM scope
Resource appropriateness
Across the evidence-based medicine community (hundreds of thousands of people communicating the results of healthcare research through systematic reviews and expressing the findings from a body of evidence), the effect estimate synthesized from a body of evidence is the primary method of expressing quantitative results. Standardization is necessary to support interoperability across the evidence-based medicine domain.
Expected implementations
Many knowledge producers who express the biomedical research community knowledge will be the implementers using this resources. Examples of these knowledge producers include Agency for Healthcare Research and Quality (AHRQ), Centers for Disease Control and Prevention (CDC), Cochrane, Duodecim Medical Publications Ltd (from the Finnish Medical Society), EBSCO Health, MAGIC (stands for Making GRADE the Irresistible Choice), and numerous guideline development organizations.
Content sources
Example Scenarios
Resource Relationships
Resource Boundaries
Timelines
gForge Users
When Resource Proposal Is Complete
When you have completed your proposal, please send an email to FMGcontact@HL7.org
